{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:54:27Z","timestamp":1787064867346,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T00:00:00Z","timestamp":1417132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s12032-014-0320-1","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T12:33:00Z","timestamp":1417437180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer\/T cell lymphoma, nasal type"],"prefix":"10.1007","volume":"32","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"issue":"5","key":"320_CR1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10428190902803669","volume":"50","author":"HS Kim","year":"2009","unstructured":"Kim HS, Kim KH, Kim KH, Chang MH, Ji SH, et al. Whole blood Epstein\u2013Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer\/T-cell lymphoma. Leuk Lymphoma. 2009;50(5):757\u201363.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"320_CR2","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","volume":"15","author":"YX Li","year":"2009","unstructured":"Li YX, Liu QF, Fang H, Qi SN, Wang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma. Clin Cancer Res. 2009;15(8):2905\u201312.","journal-title":"Clin Cancer Res"},{"key":"320_CR3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","volume":"100","author":"CC Li","year":"2004","unstructured":"Li CC, Tien HF, Tang JL, Yao M, Chen YC, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/Tcell or T-cell lymphoma. Cancer. 2004;100:366\u201375.","journal-title":"Cancer"},{"issue":"1","key":"320_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","volume":"70","author":"MJ Huang","year":"2008","unstructured":"Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, et al. Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys. 2008;70(1):166\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"320_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12185-012-1174-y","volume":"96","author":"L Wang","year":"2012","unstructured":"Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE\/IIE extranodal natural killer\/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Int J Hematol. 2012;96(5):617\u201323.","journal-title":"Int J Hematol"},{"key":"320_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","volume":"83","author":"B Wang","year":"2008","unstructured":"Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type. Am J Hematol. 2008;83:795\u20139.","journal-title":"Am J Hematol"},{"issue":"33","key":"320_CR7","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29(33):4410\u20136.","journal-title":"J Clin Oncol"},{"key":"320_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.27752","volume":"119","author":"L Wang","year":"2013","unstructured":"Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, et al. First-line combination of gemcitabine, oxaliplatin, and l-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma. Cancer. 2013;119:348\u201355.","journal-title":"Cancer"},{"key":"320_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12032-014-0860-4","volume":"31","author":"W Liang","year":"2014","unstructured":"Liang W, Wei-da W, Zhong-jun X, Yu-jing Z, Jin X, Yue L. Combination of gemcitabine, l-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE\/IIE extranodal natural killer\/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Med Oncol. 2014;31:860.","journal-title":"Med Oncol"},{"issue":"5","key":"320_CR10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","volume":"82","author":"YX Li","year":"2012","unstructured":"Li YX, Wang H, Jin J, Wang WH, Liu QF, et al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1809\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"320_CR11","first-page":"285","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"JK Chan","year":"2008","unstructured":"Chan JK, Quintanilla-Martinez L, Ferry JA, Peh S-C. Extranodal NK\/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 285\u20138."},{"issue":"17","key":"320_CR12","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113(17):3931\u20137.","journal-title":"Blood"},{"key":"320_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54\u201363.","journal-title":"J Clin Oncol"},{"key":"320_CR14","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","volume":"114","author":"Z-Y Wang","year":"2009","unstructured":"Wang Z-Y, Li Y-X, Wang W-H, Jin J, Wang H, et al. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents. Blood. 2009;114:4771\u20136.","journal-title":"Blood"},{"key":"320_CR15","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/j.1349-7006.2009.01319.x","volume":"100","author":"TM Kim","year":"2009","unstructured":"Kim TM, Heo DS. Extranodal NK\/T-cell lymphoma, nasal type: new staging system and treatment strategies. Cancer Sci. 2009;100:2242\u20138.","journal-title":"Cancer Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0320-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0320-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T20:50:49Z","timestamp":1566075049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0320-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0320-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,28]]},"article-number":"320"}}